CD69 is known as an activation marker and is expressed on infiltrated leukocytes at inflammatory sites under various chronic human inflammatory diseases, such as rheumatoid arthritis (30), systemic sclerosis (31), allergic asthma (32), and atopic dermatitis (33). This evidence concerns the gene CD69 and systemic sclerosis.